MEDICAL NEWS TODAY | DAILY NEWS
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
 
 
Weight loss drugs improve heart health regardless of amount of weight lost: study
 
READ ON
→
Medicare 2026: What to know about premiums, Part D, impact from government shutdown
 
READ ON
→
New retinal implant may restore central vision in people with advanced AMD
 
READ ON
→
 
 
 
 
 
Expert perspectives: The future of Huntington’s disease management and treatment